Michael R. Campoli

Most-cited papers

1. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

   Michael R. Campoli, S. Ferrone

   2008Oncogene387 citations Open access

   Semantic Scholar

   Save

2. Human Leukocyte Antigen and Antigen Processing Machinery Component Defects in Astrocytic Tumors

   A. Facoetti, R. Nano, P. Zelini, P. Morbini +4 more

   2005Clinical Cancer Research194 citations Open access

   Semantic Scholar

   Save

3. Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.

   Michael R. Campoli, Chien-Chung Chang, T. Kageshita, Xin-Hui Wang +2 more

   2004Critical Reviews in Immunology190 citations

   Semantic Scholar

   Save

4. HLA class I antigen loss, tumor immune escape and immune selection.

   Michael R. Campoli, Chien-Chung Chang, S. Ferrone

   2002Vaccine131 citations

   Semantic Scholar

   Save

5. CSPG4 in cancer: multiple roles.

   Xiang Wang, Yang-Yang Wang, Ling Yu, K. Sakakura +9 more

   2010Current molecular medicine130 citations

   Semantic Scholar

   Save

6. Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.

   Chien-Chung Chang, Michael R. Campoli, S. Ferrone

   2005Advances in Cancer Research118 citations

   Semantic Scholar

   Save

7. Immune Selection of Hot-Spot β2-Microglobulin Gene Mutations, HLA-A2 Allospecificity Loss, and Antigen-Processing Machinery Component Down-Regulation in Melanoma Cells Derived from Recurrent Metastases following Immunotherapy1

   Chien-Chung Chang, Michael R. Campoli, N. Restifo, Xin-Hui Wang +1 more

   2005Journal of Immunology108 citations Open access

   Semantic Scholar

   Save

8. Functional and clinical relevance of chondroitin sulfate proteoglycan 4.

   Michael R. Campoli, S. Ferrone, Xin-Hui Wang

   2010Advances in Cancer Research103 citations

   Semantic Scholar

   Save

9. Tumor escape mechanisms: Potential role of soluble HLA antigens and NK cells activating ligands

   Michael R. Campoli, S. Ferrone

   2008Tissue Antigens83 citations Open access

   Semantic Scholar

   Save

10. Immunotherapy of malignant disease with tumor antigen (TA)-specific monoclonal antibodies: does its therapeutic efficacy require cooperation with TA-specific CTL?

    Michael R. Campoli, R. Ferris, S. Ferrone, Xin-Hui Wang

    2009Clinical Cancer Research79 citations Open access

    Semantic Scholar

    Save

11. HLA class I defects in malignant lesions: what have we learned?

    Chien-Chung Chang, Michael R. Campoli, S. Ferrone

    2003The Keio Journal of Medicine78 citations Open access

    Semantic Scholar

    Save

12. Mechanisms of tumor evasion.

    Michael R. Campoli, S. Ferrone, A. Zea, P. Rodriguez +1 more

    2005Cancer treatment and research68 citations

    Semantic Scholar

    Save

13. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.

    Xin-Hui Wang, Michael R. Campoli, Hyun Suk Cho, T. Ogino +5 more

    2005JIM - Journal of Immunological Methods62 citations

    Semantic Scholar

    Save

14. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.

    Michael R. Campoli, D. Brodland, J. Zitelli

    2014Journal of American Academy of Dermatology58 citations

    Semantic Scholar

    Save

15. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs surgery: a five-year, multicenter, prospective cohort study.

    Amanda J. Tschetter, Michael R. Campoli, J. Zitelli, D. Brodland

    2020Journal of American Academy of Dermatology51 citations

    Semantic Scholar

    Save

16. HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

    Chien-Chung Chang, Michael R. Campoli, S. Ferrone

    2004Current Opinion in Immunology46 citations

    Semantic Scholar

    Save

17. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

    Michael R. Campoli, S. Ferrone

    2011Seminars in Immunopathology40 citations Open access

    Semantic Scholar

    Save

18. Immunotherapy of Melanoma Targeting Human High Molecular Weight Melanoma‐Associated Antigen: Potential Role of Nonimmunological Mechanisms

    Chien-Chung Chang, Michael R. Campoli, W. Luo, Wan-Zhou Zhao +2 more

    2004Annals of the New York Academy of Sciences37 citations

    Semantic Scholar

    Save

19. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.

    Toshiro Kageshita, T. Ishihara, Michael R. Campoli, S. Ferrone

    2005Tissue Antigens32 citations

    Semantic Scholar

    Save

20. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.

    Xin-Hui Wang, Michael R. Campoli, E. Ko, W. Luo +1 more

    2004JIM - Journal of Immunological Methods29 citations

    Semantic Scholar

    Save

21. HLA Antigen Changes in Malignant Tumors of Mammary Epithelial Origin: Molecular Mechanisms and Clinical Implications

    Michael R. Campoli, Chien-Chung Chang, S. Oldford, Allison D. Edgecombe +2 more

    2004Breast Disease28 citations

    Semantic Scholar

    Save

22. T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?

    Michael R. Campoli, S. Ferrone

    2004Expert Review of Vaccines10 citations

    Semantic Scholar

    Save

23. A fresh look at an old story: revisiting HLA class II antigen expression by melanoma cells

    S. Ferrone, Michael R. Campoli

    20069 citations

    Semantic Scholar

    Save

24. Development and validation of a nomogram incorporating gene expression profiling and clinical factors for accurate prediction of metastasis in patients with cutaneous melanoma following Mohs micrographic surgery.

    R. Thorpe, K. Covington, H. Caruso, A. Quick +10 more

    2021Journal of American Academy of Dermatology8 citations Open access

    Semantic Scholar

    Save

25. Immune Escape: Tumor induced immune suppression and immune escape: Mechanisms and Possible Solutions

    T. Whiteside, Michael R. Campoli, S. Ferrone

    20057 citations

    Semantic Scholar

    Save

26. HLA antigen expression in melanocytic lesions: Is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?

    Michael R. Campoli, J. Fitzpatrick, W. High, S. Ferrone

    2012Journal of American Academy of Dermatology6 citations Open access

    Semantic Scholar

    Save

27. Tumor-Induced Immune Suppression and Immune Escape

    Michael R. Campoli, S. Ferrone

    20062 citations

    Semantic Scholar

    Save

28. Mohs Micrographic Surgery for the Treatment of Cutaneous Melanoma

    Michael R. Campoli, Scott R. Freeman, D. Brodland, J. Zitelli

    20121 citations

    Semantic Scholar

    Save

29. HLA Class I Antigen-Processing Machinery and HLA Class I Antigen-Derived Peptide-Complex Defects in Tumor-Cell Escape

    Michael R. Campoli, Chien-Chung Chang, Xin-Hui Wang, S. Ferrone

    20041 citations

    Semantic Scholar

    Save

30. Benign melanocytic tumors

    Michael R. Campoli, P. Walsh

    20110 citations

    Semantic Scholar

    Save

31. Anti-inflammatory biologic therapies and immune surveillance of melanoma

    Michael R. Campoli, S. Ferrone

    20080 citations Open access

    Semantic Scholar

    Save

32. CTL-Tumor Cell Interaction: The Generation of Molecular Probes of Monitoring the HLA-A*0201-HER-2/neu Peptide Complex

    Michael R. Campoli

    20050 citations

    Semantic Scholar

    Save

33. Cytotoxic T lymphocyte - tumor cell interaction: Monitoring HLA class I antigen and HLA class I antigen - tumor antigen derived peptide complex expression by malignant cells

    Michael R. Campoli

    20050 citations

    Semantic Scholar

    Save